We are live on
!
Find out more
JIC
Juniper Investment Company Portfolio holdings
AUM
$313M
1-Year Est. Return
79.58%
This Fund
S&P 500
This Quarter
Est. Return
+8.28%
1 Year Est. Return
+79.58%
3 Year Est. Return
+386.55%
5 Year Est. Return
+450.32%
10 Year Est. Return
–
AUM
$291M
AUM Growth
+$29.4M
(+11%)
Cap. Flow
+$8.33M
Cap. Flow
% of AUM
2.86%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
2
Reduced
1
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Orthofix Medical
OFIX
|
+$10.1M |
| 2 |
LSI Industries
LYTS
|
+$4.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Artivion
AORT
|
+$6.44M |
| 2 |
Precision Optics
POCI
|
+$67.4K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 54.69% |
| 2 | Technology | 19.8% |
| 3 | Consumer Staples | 19.62% |
| 4 | Industrials | 5.88% |
Similar funds
WMIG
FA
MIM
PAM
SL
TF
EWA
WIC
Juniper Investment Company's Q4 2025 Portfolio in Review
As of Q4 2025, Juniper Investment Company held 9 positions worth $291M, up 11% from $261M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Juniper Investment Company's Q4 2025 filing shows 2 increased, 1 reduced and 1 closed positions. The largest sale was Artivion, an estimated $6.44M.
By sector, the portfolio is most concentrated in Healthcare at 55% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Staples.
- Juniper Investment Company added most to Orthofix Medical in Q4 2025, an estimated $10.1M increase.
- Juniper Investment Company's biggest Q4 2025 reduction was Artivion, cutting an estimated $6.44M.
- Juniper Investment Company fully exited Precision Optics in Q4 2025, selling an estimated $67.4K.
- Juniper Investment Company's ten largest holdings make up 100% of its $291M portfolio in Q4 2025.
- Juniper Investment Company opened 0 new positions and closed 1 in Q4 2025.
- Juniper Investment Company's portfolio value rose 11% quarter-over-quarter to $291M.
Based on Juniper Investment Company's 13F filing for Q4 2025, filed 17 Feb 2026.